The traditionally available methods for studying a biopsy are not scalable, provide mediocre results, and are labor-intensive as they rely too much on the technician's skill to isolate the correct cell population from the slide. Quantumcyte automates this process, gets tremendous results, and can run hundreds of biopsies in one given shift.
This clip of Talk is Biotech! is powered by Scispot.io, hosted by the company's CEO Guru Singh.
Quantumcyte'sinnovativetechnology
0 Comments